The road to precision

How Roche’s Syapse deal supports the pharma’s precision medicine strategy

Roche’s deal with Syapse is the latest in a series of partnerships intended to overcome challenges associated with developing and commercializing personalized medicine for small patient populations. The partnering strategy is two-pronged: accumulate a vast data set, and conduct lots of small projects to increase the number of ways it can analyze the data.

Gregg Talbert, global head of digital and personalized health care partnering, said Roche is collecting its own clinical data and seeking partners whose data sets either contain different types of data on the same patient populations, or cover different types of patients within its focus areas in oncology, neurology and ophthalmology.

He said while scale

Read the full 1075 word article

User Sign In